These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 32950646)
21. Milk thistle and the treatment of hepatitis. Giese LA Gastroenterol Nurs; 2001; 24(2):95-7. PubMed ID: 11847735 [TBL] [Abstract][Full Text] [Related]
22. Silybin and the liver: from basic research to clinical practice. Loguercio C; Festi D World J Gastroenterol; 2011 May; 17(18):2288-301. PubMed ID: 21633595 [TBL] [Abstract][Full Text] [Related]
23. Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer. Fallah M; Davoodvandi A; Nikmanzar S; Aghili S; Mirazimi SMA; Aschner M; Rashidian A; Hamblin MR; Chamanara M; Naghsh N; Mirzaei H Biomed Pharmacother; 2021 Oct; 142():112024. PubMed ID: 34399200 [TBL] [Abstract][Full Text] [Related]
24. Attenuation of UVA-induced damage to human keratinocytes by silymarin. Svobodová A; Zdarilová A; Malisková J; Mikulková H; Walterová D; Vostalová J J Dermatol Sci; 2007 Apr; 46(1):21-30. PubMed ID: 17289350 [TBL] [Abstract][Full Text] [Related]
25. The roles of Akt and MAPK family members in silymarin's protection against UV-induced A375-S2 cell apoptosis. Li LH; Wu LJ; Tashiro SI; Onodera S; Uchiumi F; Ikejima T Int Immunopharmacol; 2006 Feb; 6(2):190-7. PubMed ID: 16399623 [TBL] [Abstract][Full Text] [Related]
26. Effects of Silymarin on Diabetes Mellitus Complications: A Review. Stolf AM; Cardoso CC; Acco A Phytother Res; 2017 Mar; 31(3):366-374. PubMed ID: 28124457 [TBL] [Abstract][Full Text] [Related]
27. Silymarin: not just another antioxidant. Camini FC; Costa DC J Basic Clin Physiol Pharmacol; 2020 Mar; 31(4):. PubMed ID: 32134732 [TBL] [Abstract][Full Text] [Related]
28. The study of flavonolignan association patterns in fruits of diverging Silybum marianum (L.) Gaertn. chemotypes provides new insights into the silymarin biosynthetic pathway. Martinelli T; Whittaker A; Benedettelli S; Carboni A; Andrzejewska J Phytochemistry; 2017 Dec; 144():9-18. PubMed ID: 28863306 [TBL] [Abstract][Full Text] [Related]
29. Hepatic metabolism and biliary excretion of silymarin flavonolignans in isolated perfused rat livers: role of multidrug resistance-associated protein 2 (Abcc2). Miranda SR; Lee JK; Brouwer KL; Wen Z; Smith PC; Hawke RL Drug Metab Dispos; 2008 Nov; 36(11):2219-26. PubMed ID: 18687803 [TBL] [Abstract][Full Text] [Related]
30. Silymarin and Its Role in Chronic Diseases. Neha ; Jaggi AS; Singh N Adv Exp Med Biol; 2016; 929():25-44. PubMed ID: 27771919 [TBL] [Abstract][Full Text] [Related]
31. Silymarin improved diet-induced liver damage and insulin resistance by decreasing inflammation in mice. Guo Y; Wang S; Wang Y; Zhu T Pharm Biol; 2016 Dec; 54(12):2995-3000. PubMed ID: 27387273 [TBL] [Abstract][Full Text] [Related]
34. Activities of silymarin and its flavonolignans upon low density lipoprotein oxidizability in vitro. Skottová N; Krecman V; Simánek V Phytother Res; 1999 Sep; 13(6):535-7. PubMed ID: 10479770 [TBL] [Abstract][Full Text] [Related]
35. Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review. Mastron JK; Siveen KS; Sethi G; Bishayee A Anticancer Drugs; 2015 Jun; 26(5):475-86. PubMed ID: 25603021 [TBL] [Abstract][Full Text] [Related]